GFPT2 and colonic neoplasm: In addition to affecting the immune microenvironment of pancreatic cancer, GFPT2 has also been reported to be related to the malignant biological behavior of cancer cells in a variety of other cancers including colon cancer, breast cancer and serous ovarian cancer [18–20].